Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
- PMID: 32473595
- PMCID: PMC7608336
- DOI: 10.1038/s41386-020-0725-9
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
Abstract
Major depressive disorder is associated with lowered mood, anxiety, anhedonia, sleep problems, and cognitive impairments. Many of these functions are regulated by μ-opioid receptor (MOR) system. Preclinical, in vivo, and post-mortem studies have however yielded inconclusive results regarding the role of the MOR in depression and anxiety. Moreover, it is not known whether alterations in MOR are already present in subclinical depression and anxiety. In a large-scale retrospective cross-sectional study we pooled data from 135 (113 males and 22 females) healthy subjects whose brain's MOR availability was measured with positron emission tomography (PET) using an agonist radioligand [11C]carfentanil that has high affinity for MORs. Depressive and anxious symptomology was addressed with BDI-II and STAI-X questionnaires, respectively. Both anxiety and depression scores in the subclinical range were negatively associated with MOR availability in cortical and subcortical areas, notably in amygdala, hippocampus, ventral striatum, and orbitofrontal and cingulate cortices. We conclude that dysregulated MOR availability is involved in altered mood and pathophysiology of depression and anxiety disorders.
Figures




Similar articles
-
Seasonal Variation in the Brain μ-Opioid Receptor Availability.J Neurosci. 2021 Feb 10;41(6):1265-1273. doi: 10.1523/JNEUROSCI.2380-20.2020. Epub 2020 Dec 23. J Neurosci. 2021. PMID: 33361461 Free PMC article.
-
μ-opioid receptor availability is associated with sex drive in human males.Cogn Affect Behav Neurosci. 2022 Apr;22(2):281-290. doi: 10.3758/s13415-021-00960-3. Epub 2021 Nov 22. Cogn Affect Behav Neurosci. 2022. PMID: 34811707 Free PMC article.
-
Interindividual variability and lateralization of μ-opioid receptors in the human brain.Neuroimage. 2020 Aug 15;217:116922. doi: 10.1016/j.neuroimage.2020.116922. Epub 2020 May 11. Neuroimage. 2020. PMID: 32407992
-
Potential roles for opioid receptors in motivation and major depressive disorder.Prog Brain Res. 2018;239:89-119. doi: 10.1016/bs.pbr.2018.07.009. Epub 2018 Sep 19. Prog Brain Res. 2018. PMID: 30314570 Review.
-
Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.Curr Neurol Neurosci Rep. 2017 Aug 18;17(10):76. doi: 10.1007/s11910-017-0788-0. Curr Neurol Neurosci Rep. 2017. PMID: 28822071 Review.
Cited by
-
Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems.Ann Neurol. 2024 Apr;95(4):802-816. doi: 10.1002/ana.26871. Epub 2024 Jan 12. Ann Neurol. 2024. PMID: 38146745 Free PMC article.
-
Mu-opioid receptor system modulates responses to vocal bonding and distress signals in humans.Philos Trans R Soc Lond B Biol Sci. 2022 Nov 7;377(1863):20210181. doi: 10.1098/rstb.2021.0181. Epub 2022 Sep 21. Philos Trans R Soc Lond B Biol Sci. 2022. PMID: 36126675 Free PMC article.
-
Amygdala Intercalated Cells: Gate Keepers and Conveyors of Internal State to the Circuits of Emotion.J Neurosci. 2022 Dec 7;42(49):9098-9109. doi: 10.1523/JNEUROSCI.1176-22.2022. J Neurosci. 2022. PMID: 36639901 Free PMC article. Review.
-
The utility of PET imaging in depression.Front Psychiatry. 2024 Apr 22;15:1322118. doi: 10.3389/fpsyt.2024.1322118. eCollection 2024. Front Psychiatry. 2024. PMID: 38711875 Free PMC article. Review.
-
Contribution of the μ-opioid receptor system to affective disorders in temporal lobe epilepsy: A bidirectional relationship?Epilepsia. 2023 Feb;64(2):420-429. doi: 10.1111/epi.17463. Epub 2022 Dec 28. Epilepsia. 2023. PMID: 36377838 Free PMC article.
References
-
- Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 2007;64:651–60. - PubMed
-
- Davis M. Morphine and naloxone: effects on conditioned fear as measured with the potentiated startle paradigm. Eur J Pharmacol. 1979;54:341–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials